Compare FMS & WLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FMS | WLK |
|---|---|---|
| Founded | 1996 | 1986 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 10.3B |
| IPO Year | 2005 | 2004 |
| Metric | FMS | WLK |
|---|---|---|
| Price | $23.56 | $78.36 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 15 |
| Target Price | $30.00 | ★ $106.87 |
| AVG Volume (30 Days) | 755.8K | ★ 1.2M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.57% | 1.90% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.70 |
| Revenue | N/A | ★ $11,170,000,000.00 |
| Revenue This Year | N/A | $5.51 |
| Revenue Next Year | $3.83 | $3.74 |
| P/E Ratio | ★ $15.62 | $113.64 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $20.02 | $56.33 |
| 52 Week High | $27.64 | $124.23 |
| Indicator | FMS | WLK |
|---|---|---|
| Relative Strength Index (RSI) | 42.80 | 50.16 |
| Support Level | $23.52 | $70.80 |
| Resistance Level | $23.91 | $78.26 |
| Average True Range (ATR) | 0.49 | 2.88 |
| MACD | -0.18 | 0.65 |
| Stochastic Oscillator | 4.87 | 72.40 |
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Westlake is a forward-integrated commodity chemicals firm based in Houston. It began as a single low-density polyethylene plant and expanded its capabilities to include ethylene, vinyl chloride monomers, and polyvinyl chloride over the next two decades. The acquisition of Axiall in 2016 made it a North American leader in chlor-alkali and PVC. Today, Westlake has two defined segments: performance and essential materials, and housing and infrastructure products. The HIP segment began operating in 2022 following a series of acquisitions in the building products space. The firm aims to maximize the value of its chemical production by integrating with the HIP segment, realizing the higher margins of finished commercial goods.